NYSE:PACSHealthcare
Is PACS Group (PACS) Still Attractive After Its Sharp Pullback From Recent Highs?
Wondering if PACS Group at US$30.59 is still priced for opportunity or already reflects the story? This breakdown will help you frame what the current share price might be implying.
The stock has had a mixed run, with a 1 year return of 180.4% contrasted by a 7 day return of an 8.5% decline, a 30 day return of a 22.2% decline, and a year to date return of a 22.6% decline, which can change how the market views its risk and reward trade off.
Recent coverage of PACS Group has focused on its...